ANIP

MKT CAP:$2B

ANI Pharmaceuticals Inc

Market Cap

$2B

Healthcare·Drug Manufacturers - Specialty & Generic·🇺🇸 United States·NASDAQ

Healthcare·Drug·🇺🇸·NASDAQ

Stock Price

$80.13+$1.70 (+2.17%)

Jun 8, 2026

52W High $98.8152W Low $62.12

Company Details

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortro...

CEO

—

IPO Date

May 5, 2000

Website

www.anipharmaceuticals.com

Key Metrics TTM

Revenue

$924M

+37.0% YoY

Net Income

$90M

EPS (Diluted)

Free Cash Flow

$166M

Revenue / Share

$42.88

Gross Margin

65.9%

Operating Margin

13.4%

Net Margin

9.7%

FCF Margin

17.9%

P/S

1.9x

P/E

19.4x

Earnings Reports

Q2 2026

Aug 7, 2026

PENDING

Q1 2026

May 8, 2026

$237M+20.5%

FY 2025

Feb 27, 2026

$883M+43.8%

Q4 2025

Feb 27, 2026

$247M+29.6%

Q3 2025

Nov 7, 2025

$228M+53.6%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee